LHX6 and cervical cancer: As shown in Figure 1F, the relative mRNA quantity of LHX6EX(+12) group was higher than that of the LHX6EX(−12) group in cancer tissues (p = 0.0147), indicating that the LHX6EX(+12) group was the dominant component of LHX6 in cervical cancer.